Cannabidiol (CBD) Market

By Source;

Hemp and Marijuana

By Product;

CBD Oil, CBD Isolates and Others

By Sales Type;

B2B and B2C

By End-use;

Medical and Personal Use

By Geography;

North America, Europe, Asia Pacific, Middle East & Africa and Latin America - Report Timeline (2021 - 2031).
Report ID: Rn124509333 Published Date: August, 2025 Updated Date: September, 2025

Cannabidiol (CBD) Market Overview

Cannabidiol (CBD) Market (USD Million)

Cannabidiol (CBD) Market was valued at USD 6,453.95 million in the year 2024. The size of this market is expected to increase to USD 59,484.69 million by the year 2031, while growing at a Compounded Annual Growth Rate (CAGR) of 37.3%.


Cannabidiol (CBD) Market

*Market size in USD million

CAGR 37.3 %


Study Period2025 - 2031
Base Year2024
CAGR (%)37.3 %
Market Size (2024)USD 6,453.95 Million
Market Size (2031)USD 59,484.69 Million
Market ConcentrationLow
Report Pages320
6,453.95
2024
59,484.69
2031

Major Players

  • ENDOCA
  • Cannoid, LLC
  • Medical Marijuana, Inc.
  • Folium Europe B.V.
  • Canopy Growth Corporation
  • Elixinol
  • NuLeaf Naturals, LLC
  • Isodiol International, Inc.
  • PharmaHemp
  • The Cronos Group

Market Concentration

Consolidated - Market dominated by 1 - 5 major players

Cannabidiol (CBD) Market

Fragmented - Highly competitive market without dominant players


The Cannabidiol (CBD) Market is gaining strong traction as consumers increasingly pursue natural alternatives to conventional treatments. The demand for CBD-infused products is rising among individuals managing issues like stress, pain, and insomnia. An estimated 68% of users are driven by wellness goals, highlighting the mainstream appeal of CBD in personal health routines.

Greater Awareness Fueling Market Uptake
Awareness of CBD's health benefits continues to grow, pushing adoption across a broader demographic. Around 57% of consumers believe CBD helps reduce inflammation and promote calmness. This rising confidence is reshaping buying behavior, as more individuals turn to holistic, nature-based solutions.

Regulatory Clarity Enhances Trust
Better-defined CBD regulations are enabling safer product development and fostering brand credibility. About 52% of manufacturers have increased compliance efforts, focusing on product quality and safety. These regulatory improvements are encouraging both investors and consumers to engage more actively with the CBD space.

Consumer Behavior Driving Growth
As preferences shift toward non-addictive, plant-based therapies, CBD is gaining traction as a viable alternative to pharmaceuticals. Nearly 61% of users have reported reducing dependence on synthetic medications after regular CBD usage. This trend reflects a broader move toward natural wellness, sustaining growth in the CBD market.

  1. Introduction
    1. Research Objectives and Assumptions
    2. Research Methodology
    3. Abbreviations
  2. Market Definition & Study Scope
  3. Executive Summary
    1. Market Snapshot, By Source
    2. Market Snapshot, By Product
    3. Market Snapshot, By Sales Type
    4. Market Snapshot, By End User
    5. Market Snapshot, By Region
  4. Cannabidiol (CBD) Market Dynamics
    1. Drivers, Restraints and Opportunities
      1. Drivers
        1. Growing Consumer Awareness and Acceptance

        2. Increasing Scientific Research and Clinical Trials

        3. Rising Demand for Natural and Organic Wellness Solutions

      2. Restraints
        1. Regulatory Uncertainty

        2. Product Quality and Standardization

        3. Marketing and Advertising Restrictions

      3. Opportunities
        1. Development of Pharmaceutical-Grade CBD Products

        2. Delivery Method Advancements

        3. Improved Cultivation Practices

    2. PEST Analysis
      1. Political Analysis
      2. Economic Analysis
      3. Social Analysis
      4. Technological Analysis
    3. Porter's Analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Buyers
      3. Threat of Substitutes
      4. Threat of New Entrants
      5. Competitive Rivalry
  5. Market Segmentation
    1. Cannabidiol (CBD) Market, By Source, 2021 - 2031 (USD Million)
      1. Hemp
      2. Marijuana
    2. Cannabidiol (CBD) Market, By Product, 2021 - 2031 (USD Million)

      1. CBD Oil

      2. CBD Isolates

      3. Others

    3. Cannabidiol (CBD) Market, By Sales Type, 2021 - 2031 (USD Million)
      1. B2B
      2. B2C
    4. Cannabidiol (CBD) Market, By End User, 2021 - 2031 (USD Million)
      1. Medical

      2. Personal Use

    5. Cannabidiol (CBD) Market, By Geography, 2021 - 2031 (USD Million)
      1. North America
        1. United States
        2. Canada
      2. Europe
        1. Germany
        2. United Kingdom
        3. France
        4. Italy
        5. Spain
        6. Nordic
        7. Benelux
        8. Rest of Europe
      3. Asia Pacific
        1. Japan
        2. China
        3. India
        4. Australia & New Zealand
        5. South Korea
        6. ASEAN (Association of South East Asian Countries)
        7. Rest of Asia Pacific
      4. Middle East & Africa
        1. GCC
        2. Israel
        3. South Africa
        4. Rest of Middle East & Africa
      5. Latin America
        1. Brazil
        2. Mexico
        3. Argentina
        4. Rest of Latin America
  6. Competitive Landscape Analysis
    1. Company Profiles
      1. ENDOCA
      2. Cannoid, LLC
      3. Medical Marijuana, Inc.
      4. Folium Europe B.V.
      5. Canopy Growth Corporation
      6. Elixinol
      7. NuLeaf Naturals, LLC
      8. Isodiol International, Inc.
      9. PharmaHemp
      10. The Cronos Group
  7. Analyst Views
  8. Future Outlook of the Market